Insight Molecular Diagnostics Inc. IMDX
2.49 USD +0.03 (+1.22%)
At closeNov 6, 2026, 4:00 PM EST
2.49 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
2.43 Day range 2.61
2.46 52-week range 8.48
- YTD
- -66.80%
- 1 year
- -61.69%
- Market cap
- 81.48M
- EPS (ttm)
- -1.52
- YTD return
- -66.80%
- 1-year return
- -61.69%
- Volume
- 94.89K
- Avg volume
- 245.19K
- Open
- 2.46
- Previous close
- 2.46
- Day's range
- 2.43 – 2.61
- 52-week range
- 2.46 – 8.48
ALL -80.51 (-97.00%)
Financials — quick view
IMDX Revenue — quarterly 239.00K
IMDX Net income — quarterly -11.26M
IMDX EPS — quarterly -0.31
News
iMDx to Release Third Quarter Results on November 16, 2026 
iMDx Amends Chronix Merger Agreement, Replacing Ongoing 10% CNI Monitor Royalty With 10% Sale Payment Upon CNI Monitor Sale 
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8 
Transcript: Insight Molecular Q2 2026 Earnings Conference Call - Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For Reliable dd-cfDNA Results In Transplanted Organ Health Monitoring
CORRECTION: Insight Molecular Q2 Adj. EPS $(0.23) Beats $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate - 12 Health Care Stocks Moving In Friday's After-Market Session
Insight Molecular Q1 2026 Earnings Call Transcript - Insight Molecular Q1 Adj. EPS $(0.28) Misses $(0.26) Estimate, Sales $32.000K Miss $300.000K Estimate
Earnings Scheduled For May 13, 2026
Your note
Sign in to keep a note on IMDX — it syncs with the Stock Master app.